R&D Podcasts | pharmaphorum

Podcasts

R&D

Dr Jörg Schüttrumpf, Chief Scientific Innovation Officer of Grifols, discusses advancing immunoglobulin (or IG) treatment for immune disorders.

R&D

Markus Vossman, Germany general manager at Illumina, discusses innovative genomic applications and projects in the region.

R&D

Benedict Cross, Chief Technology Officer at PhoreMost, discusses targeted protein degradation.

R&D

In a new pharmaphorum podcast, Punit Dhillon, CEO of Skye Bioscience, discusses CB1 inhibitor antibodies in the obesity space.

R&D

In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.

R&D

Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.